CD1d−/− mice fed with HFHC were protected from NASH, did not gain weight, had normal levels of ALT (liver damage marker), fasting glucose, a-SMA (fibrosis marker) and lower or no steatosis (99). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.